Epstein-Barr virus infection
MONDO:0005111An infection that is caused by Epstein-Barr virus.
Also known as: EBV infection, Epstein-Barr Virus infection, Human gammaherpesvirus 4 caused disease or disorder, Human gammaherpesvirus 4 disease or disorder, Human gammaherpesvirus 4 infectious disease, EBV infections, Epstein Barr Virus infections, Herpesvirus 4 infections, Human
63 clinical trials for this condition and its sub-types, 61 tagged with Epstein-Barr virus infection itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Epstein-Barr virus infection
-
Infectious mononucleosis 8 trials
-
Epstein-Barr virus hepatitis 0 trials
-
Supercharged immune cells take on Drug-Resistant infections
Disease control Stopped earlyThis trial investigates whether specially grown immune cells, called pathogen-specific cytotoxic T lymphocytes (CTLs), can safely and effectively treat stubborn infections like EBV, CMV, and adenovirus in people with weakened immune systems, such as stem cell or organ transplant …
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Experimental immune cell therapy for transplant viruses shows early promise but study halted
Disease control Stopped earlyThis early-stage trial tested whether specially grown immune cells could help transplant patients fight off stubborn viral infections. The study included 8 people who had received a stem cell or organ transplant and had ongoing infections with adenovirus, CMV, or EBV. The approac…
Phase 1/2 • Sponsor: Jessie L. Alexander, MD • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Experimental donor CAR-T therapy tested in lymphoma – trial halted early
Disease control Stopped earlyThis early-phase trial tested a new therapy called ATA3219, which uses immune cells from a healthy donor to attack cancer cells in people with relapsed or refractory B-cell non-Hodgkin lymphoma. The study aimed to check safety and see if the treatment works, but it was stopped ea…
Phase 1 • Sponsor: Atara Biotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC